Ceapro Inc V.CZO

Chemicals Specialty Chemicals

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.

TSXV:CZO - Post by User

Ceapro Inc > UofA study results out

<< Previous

Bullboard Posts

Next >>

Comment by Ciaoon Apr 08, 2021 11:05am

102 Views

Post# 32956501

RE:RE:RE:RE:RE:RE:RE:RE:RE:UofA study results out

5 - 10 years is too much of a stretch here

CZO already mentioned that they are targeting a NCC for 2021 in their presentations and still have an consultant for negotiations

PGX Oat BG impregnated with CoQ10 had an economic barrier, sodium alginate will not

Mofonomo wrote: Publishing the three abstracts is great news.

The thing is though that this is still base building research. They'll likely have to do additional studies on each compound separately and maybe even per application, either on their own or in a partnership with companies that have specific commerical applications already.

I think the time horizon is still long or very long on this, maybe 5-10 years out. Also think that Retail, nowadays, is mostly interested in daily or weekly plays.